|
End-of-day quote
Egyptian Exchange
2026-08-16
|
5-day change | 1st Jan Change | ||
| 1.540 EGP | -0.65% |
|
-1.28% | +35.09% |
| 05-17 | Macro Group Pharmaceutical Q1 consol profit egp 33.3 million | RE |
| 02-19 | Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 878M 17.46M 15.08M 14.17M 12.89M 24.24M 1.67B 24.63M 166M 64.94M 836M 65.57M 64.15M 2.78B | P/E 2026 * |
25.7x | P/E 2027 * | 17.1x |
|---|---|---|---|---|---|
| Enterprise Value | 798M 15.88M 13.71M 12.89M 11.72M 22.04M 1.52B 22.4M 151M 59.04M 760M 59.62M 58.32M 2.53B | EV / Sales 2026 * |
0.67x | EV / Sales 2027 * | 0.49x |
| Free-Float |
30.46% | Yield 2026 * |
1.95% | Yield 2027 * | 2.6% |
| 1 day | -0.65% | ||
| 1 week | -1.28% | ||
| Current month | +3.36% | ||
| 1 month | +15.79% | ||
| 3 months | +20.31% | ||
| 6 months | +17.56% | ||
| Current year | +35.09% |
| 1 week | 1.53 |  | 1.74 |
| 1 month | 1.32 | | 1.74 |
| Current year | 1.02 | | 1.74 |
| 1 year | 0.81 | | 4.11 |
| 3 years | 0.81 | | 4.11 |
| 5 years | 0.81 | | 5.28 |
| 10 years | 0.81 | | 5.28 |
| Manager | Title | Age | Since |
|---|---|---|---|
Khaled Kamel
CEO | Chief Executive Officer | - | - |
Zeina Shahin
IRC | Investor Relations Contact | - | - |
Tamer Raouf
SAM | Sales & Marketing | - | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Ahmed El-Nayeb
CHM | Chairman | - | 2001-12-31 |
Tamir Saeed
BRD | Director/Board Member | - | 2020-12-31 |
Norbert Lurz
BRD | Director/Board Member | - | 2020-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.65% | -1.28% | -28.37% | -36.89% | 17.58M | |
| -2.25% | -0.47% | +68.30% | +116.05% | 1,052B | |
| -0.66% | +0.43% | +47.39% | +51.02% | 627B | |
| -0.54% | +1.39% | +20.69% | +64.61% | 441B | |
| -1.99% | -3.32% | +38.71% | +36.26% | 349B | |
| -1.05% | -2.81% | +23.07% | +35.91% | 287B | |
| -2.12% | -3.67% | -1.14% | +5.35% | 241B | |
| -0.63% | +1.04% | +40.05% | +56.67% | 224B | |
| -1.19% | -3.41% | -9.57% | -53.50% | 202B | |
| +0.16% | +3.87% | +16.89% | +77.38% | 172B | |
| Average | -1.09% | -0.32% | +21.60% | +35.29% | 359.52B | |
| Weighted average by Cap. | -1.36% | +0.04% | +39.09% | +61.76% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.19B 23.67M 20.44M 19.21M 17.47M 32.84M 2.26B 33.38M 225M 88M 1.13B 88.86M 86.93M 3.77B | 1.55B 30.87M 26.66M 25.05M 22.78M 42.83M 2.95B 43.54M 294M 115M 1.48B 116M 113M 4.91B |
| Net income | 206M 4.1M 3.54M 3.33M 3.02M 5.69M 392M 5.78M 38.96M 15.23M 196M 15.38M 15.05M 652M | 283M 5.63M 4.86M 4.57M 4.15M 7.81M 538M 7.94M 53.52M 20.93M 270M 21.13M 20.67M 896M |
| Net Debt | -79.7M -1.59M -1.37M -1.29M -1.17M -2.2M -152M -2.24M -15.07M -5.89M -75.9M -5.95M -5.82M -252M | -110M -2.19M -1.89M -1.78M -1.61M -3.04M -209M -3.09M -20.8M -8.13M -105M -8.21M -8.04M -348M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-16 | EGP 1.540 | -0.65% | 37,832,774 |
| 26-08-13 | EGP 1.550 | -1.90% | 45,346,022 |
| 26-08-12 | EGP 1.580 | 0.00% | 66,925,294 |
| 26-08-11 | EGP 1.580 | -3.07% | 201,347,038 |
| 26-08-10 | EGP 1.630 | +4.49% | 128,353,657 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.540EGP
Average target price
1.570EGP
Spread / Average Target
+1.95%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- MCRO Stock
Select your edition
All financial news and data tailored to specific country editions
